Morgan Stanley raised the firm’s price target on Houlihan Lokey (HLI) to $213 from $192 and keeps an Overweight rating on the shares. With the M&A cycle “gaining steam,” the firm estimates M&A volumes to fully revert back to three decade averages versus nominal GDP in 2027 and is rolling its valuation year from 2026 to 2027, the analyst tells investors in a note on the Midcap Advisors group.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on HLI:
